{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:49:35Z","timestamp":1764510575165},"reference-count":15,"publisher":"Consilium Medicum","issue":"7","license":[{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Primary mediastinal large B-cell lymphoma (PMBCL) is a distinct type of large B-cell lymphoma. In this type of the disease, the neoplastic process is located in the anterior and superior mediastinum, frequently with compression of the superior vena cava and with tumor invasion into the adjacent organs and tissues: the pericardium, lung, pleura, etc. Despite the fact that in PMBCL progression, there may be involvement of extranodal organs, such as the kidney, adrenal glands, liver, and central nervous system, bone marrow (BM) injury is generally absent. Since BM injury in patients with diffuse large B-cell lymphoma is an independent poor prognostic indicator, there is reason to believe that BM involvement in PMBCL affects the prognosis. These cases may need intensified induction therapy followed by autologous hematopoietic stem cell transplantation; and BM injury should be monitored during the therapy. The paper gives reports of clinical cases of bone marrow involvement in 2 PMBCL patients treated at the National Research Center for Hematology, Ministry of Health of the Russian Federation.<\/jats:p>","DOI":"10.17116\/terarkh201789765-68","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T11:28:20Z","timestamp":1501673300000},"page":"65-68","source":"Crossref","is-referenced-by-count":2,"title":["Bone marrow involvement in primary mediastinal B-cell lymphoma"],"prefix":"10.26442","volume":"89","author":[{"given":"A U","family":"Magomedova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E A","family":"Fastova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Kovrigina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T N","family":"Obukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N I","family":"Skidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya K","family":"Mangasarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A I","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S K","family":"Kravchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2017,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Lichtenstein AK, Levine A, Taylor CR, et al. Primary mediastinal lymphoma in adults. Am J Med. 1980;68:509-514. https:\/\/doi.org\/10.1016\/0002-9343(80)90289-2","DOI":"10.1016\/0002-9343(80)90294-6"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Stein H et al. A Revised European-American Classification of Lymphoid Neoplasm\u2019s: A proposal From the International Lymphoma Study Group. Blood. 1995;2:58-59. https:\/\/doi.org\/10.1016\/s0968-6053(00)80051-4","DOI":"10.1016\/S0968-6053(00)80051-4"},{"key":"ref3","unstructured":"\u0412\u043e\u0440\u043e\u0431\u044c\u0435\u0432 \u0410.\u0418. \u0420\u0443\u043a\u043e\u0432\u043e\u0434\u0441\u0442\u0432\u043e \u043f\u043e \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438. 2-\u0435 \u0438\u0437\u0434. \u041c. \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0430. 1985;2:157-350."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Swerdlow S, Campo E, Harris N, Jaffe E. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition IARC Press, Lyon, France 2009;2:30-32. https:\/\/doi.org\/10.1093\/criticalvalues\/2.2.30","DOI":"10.1093\/criticalvalues\/2.2.30"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Fisher SG, Fisher RI. The epidemiology of non-Hodgkin lymphoma. Oncogene. 2004;23:6524-6534. https:\/\/doi.org\/10.1038\/sj.onc.1207843","DOI":"10.1038\/sj.onc.1207843"},{"key":"ref6","unstructured":"Zinzani PL, M Martelli, M Bertini, AM Gianni, L Devizzi, M. Federico, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica. 2002;87(12):1258-1264."},{"key":"ref7","unstructured":"\u041c\u0430\u043d\u0433\u0430\u0441\u0430\u0440\u043e\u0432\u0430 \u042f.\u041a., \u041c\u0430\u0433\u043e\u043c\u0435\u0434\u043e\u0432\u0430 \u0410.\u0423., \u041a\u0440\u0430\u0432\u0447\u0435\u043d\u043a\u043e \u0421.\u041a., \u0428\u043c\u0430\u043a\u043e\u0432 \u0420.\u0413. \u0438 \u0434\u0440. \u0412\u043e\u0441\u044c\u043c\u0438\u043b\u0435\u0442\u043d\u0438\u0439 \u043e\u043f\u044b\u0442 \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0430\u0433\u0440\u0435\u0441\u0441\u0438\u0432\u043d\u044b\u0445 \u0412-\u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u0445 \u043b\u0438\u043c\u0444\u043e\u043c \u0441\u0440\u0435\u0434\u043e\u0441\u0442\u0435\u043d\u0438\u044f. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2013;7:50-57."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Cazals-Hatem D, Lepage E, Brice P, Ferrant A. et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA study. Am J Surg Pathol. 1996;20(7):877-888. https:\/\/doi.org\/10.1097\/00000478-199607000-00012","DOI":"10.1097\/00000478-199607000-00012"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Abbou-Elella AA, Weisenburger DD, Vose IM, Kollath JP. et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska lymphoma study group. J Clin Oncol. 1999;17(3):784-790.","DOI":"10.1200\/JCO.1999.17.3.784"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Bishop PC, Wilson WH, Pearson D, Janik J et al. CNS involvement in primary mediastinal large B-cell lymphoma. J Clin Oncol. 1999;17(8):2479-2485.","DOI":"10.1200\/JCO.1999.17.8.2479"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Magomedova A, Kravchenko S, Kremenetskaya A, Vorobjev A et al. Treatment of diffuse large B-cell lymphomas. Blood. 2011;118(21):1153-1154.","DOI":"10.1182\/blood.V118.21.2684.2684"},{"key":"ref12","unstructured":"\u041c\u0430\u043d\u0433\u0430\u0441\u0430\u0440\u043e\u0432\u0430 \u042f.\u041a., \u041c\u0438\u0441\u044e\u0440\u0438\u043d \u0410.\u0412., \u041c\u0430\u0433\u043e\u043c\u0435\u0434\u043e\u0432\u0430 \u0410.\u0423. \u0438 \u0434\u0440. \u041c\u043e\u043b\u0435\u043a\u0443\u043b\u044f\u0440\u043d\u0430\u044f \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u043f\u0435\u0440\u0432\u0438\u0447\u043d\u043e\u0439 \u043c\u0435\u0434\u0438\u0430\u0441\u0442\u0438\u043d\u0430\u043b\u044c\u043d\u043e\u0439 \u0412-\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u043e\u0439 \u043b\u0438\u043c\u0444\u043e\u043c\u044b \u0438 \u0434\u0438\u0444\u0444\u0443\u0437\u043d\u043e\u0439 \u0412-\u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u043e\u0439 \u043b\u0438\u043c\u0444\u043e\u043c\u044b \u0441 \u043f\u0435\u0440\u0432\u0438\u0447\u043d\u044b\u043c \u0432\u043e\u0432\u043b\u0435\u0447\u0435\u043d\u0438\u0435\u043c \u043b\u0438\u043c\u0444\u0430\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0443\u0437\u043b\u043e\u0432 \u0441\u0440\u0435\u0434\u043e\u0441\u0442\u0435\u043d\u0438\u044f. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043e\u043d\u043a\u043e\u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f. 2011;4:142-145."},{"key":"ref13","unstructured":"\u041c\u0430\u043d\u0433\u0430\u0441\u0430\u0440\u043e\u0432\u0430 \u042f.\u041a. \u041c\u043e\u043b\u0435\u043a\u0443\u043b\u044f\u0440\u043d\u0430\u044f \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u0434\u0438\u0444\u0444\u0443\u0437\u043d\u043e\u0439 \u0412-\u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u043e\u0439 \u043b\u0438\u043c\u0444\u043e\u043c\u044b \u0441 \u043f\u0435\u0440\u0432\u0438\u0447\u043d\u044b\u043c \u0432\u043e\u0432\u043b\u0435\u0447\u0435\u043d\u0438\u0435\u043c \u043b\u0438\u043c\u0444\u0430\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0443\u0437\u043b\u043e\u0432 \u0441\u0440\u0435\u0434\u043e\u0441\u0442\u0435\u043d\u0438\u044f \u0438 \u043f\u0435\u0440\u0432\u0438\u0447\u043d\u043e\u0439 \u043c\u0435\u0434\u0438\u0430\u0441\u0442\u0438\u043d\u0430\u043b\u044c\u043d\u043e\u0439 \u0412-\u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u043e\u0439 \u043b\u0438\u043c\u0444\u043e\u043c\u044b: \u0414\u0438\u0441\u0441. ... \u043a\u0430\u043d\u0434. \u043c\u0435\u0434. \u043d\u0430\u0443\u043a. 2012."},{"key":"ref14","unstructured":"\u041c\u0430\u043d\u0433\u0430\u0441\u0430\u0440\u043e\u0432\u0430 \u042f.\u041a., \u041c\u0430\u0433\u043e\u043c\u0435\u0434\u043e\u0432\u0430 \u0410.\u0423., \u041d\u0435\u0441\u0442\u0435\u0440\u043e\u0432\u0430 \u0415.\u0421., \u041a\u0440\u0430\u0432\u0447\u0435\u043d\u043a\u043e \u0421.\u041a. \u0438 \u0434\u0440. \u041f\u0435\u0440\u0432\u044b\u0435 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u043f\u0435\u0440\u0432\u0438\u0447\u043d\u043e\u0439 \u043c\u0435\u0434\u0438\u0430\u0441\u0442\u0438\u043d\u0430\u043b\u044c\u043d\u043e\u0439 \u0412-\u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u043e\u0439 \u043b\u0438\u043c\u0444\u043e\u043c\u044b \u043f\u043e \u043f\u0440\u043e\u0433\u0440\u0430\u043c\u043c\u0435 R-DA-EPOCH-21. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439\u0430\u0440\u0445\u0438\u0432. 2016;7:37-42."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Dunleavy K, Pittaluga S, Maeda L, Advani R et al. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. Englad J Med. 2013;368(15):1408-1416. https:\/\/doi.org\/10.1056\/nejmoa 1214561","DOI":"10.1056\/NEJMoa1214561"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32279\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32279\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T22:32:24Z","timestamp":1634077944000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/32279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,15]]}},"URL":"https:\/\/doi.org\/10.17116\/terarkh201789765-68","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,15]]}}}